We are live on ! Find out more
PRTK

Paratek Pharmaceuticals, Inc.

Delisted

PRTK was delisted on the 20th of September, 2023.

47 hedge funds and large institutions have $21.2M invested in Paratek Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

87% less call options, than puts

Call options by funds: $96K | Put options by funds: $712K

Holders
47
Holders Change
+47
Holders Change %
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
47
Increased
Reduced
Closed
Calls
$96K
Puts
$712K
Net Calls
-$616K
Net Calls Change
-$616K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
LMF
26
LMR Master Fund
Cayman Islands
$68K +$80.6K +1,881 New
NI
27
Numeric Investors
Massachusetts
$66K +$78.5K +1,832 New
AHB
28
Abner Herrman & Brock
New Jersey
$60K +$71.4K +1,667 New
AA
29
Ancora Advisors
Ohio
$60K +$71.4K +1,667 New
Group One Trading
30
Group One Trading
Illinois
$55K +$64.7K +1,510 New
PPA
31
Parametric Portfolio Associates
Washington
$47K +$55.9K +1,305 New
HighTower Advisors
32
HighTower Advisors
Illinois
$45K +$52.9K +1,234 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$40K +$46.6K +1,088 New
Barclays
34
Barclays
United Kingdom
$36K +$42.3K +986 New
Jane Street
35
Jane Street
New York
$36K +$43.1K +1,006 New
U
36
UBS
Switzerland
$31K +$36.7K +856 New
AIG
37
American International Group
New York
$26.2K +$31K +724 New
NFA
38
Nationwide Fund Advisors
Ohio
$21K +$24.6K +575 New
WAM
39
Wolverine Asset Management
Illinois
$21K +$25.4K +592 New
TRCT
40
Tower Research Capital (TRC)
New York
$18K +$20.7K +483 New
BA
41
BlackRock Advisors
Delaware
$17K +$19.8K +463 New
TCIM
42
TIAA CREF Investment Management
New York
$10K +$11.4K +267 New
Wells Fargo
43
Wells Fargo
California
$3K +$3.56K +83 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$2K +$2.1K +49 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K +$2.31K +54 New
RFC
46
Russell Frank Company
Washington
+$257 +6 New
Ameriprise
47
Ameriprise
Minnesota
+$557 +13 New

PRTK Hedge Fund Activity: Q2 2013 in Review

47 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q2 2013, worth a combined $21.2M.

Buyers outnumbered sellers: 47 funds opened new PRTK positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

  • 47 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $21.2M of Paratek Pharmaceuticals, Inc. stock for Q2 2013.
  • 47 funds opened new Paratek Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +47 holders.

Based on aggregated 13F filings for Q2 2013.